| Mallory Ann Doyle, AGPCNP | |
|
105 Financial Pl, Elizabethtown, KY 42701-8437 | |
| (270) 765-5112 | |
| Not Available |
| Full Name | Mallory Ann Doyle |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 105 Financial Pl, Elizabethtown, Kentucky |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033718465 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 3015251 (Kentucky) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 0024183595 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginian Home Health Services | Fairfax, VA | Home health agency |
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Hospital Center Physician Group Llc | 8426231119 | 241 |
News Archive
Roche announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany.
CSL Behring announced today it has been granted national marketing authorization in Italy and Luxembourg to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. This latest authorization brings the number of countries to 28 (in Europe, Asia, North America, South America and Australia) in which Berinert is now licensed.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
The mystery of what controls the range of developmental clocks in mammals — from 22 months for an elephant to 12 days for an opossum — may lie in the strict time-keeping of pluripotent stem cells for each unique species.
› Verified 1 days ago
| Entity Name | Virginia Hospital Center Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144415480 PECOS PAC ID: 8426231119 Enrollment ID: O20110317000305 |
News Archive
Roche announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany.
CSL Behring announced today it has been granted national marketing authorization in Italy and Luxembourg to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. This latest authorization brings the number of countries to 28 (in Europe, Asia, North America, South America and Australia) in which Berinert is now licensed.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
The mystery of what controls the range of developmental clocks in mammals — from 22 months for an elephant to 12 days for an opossum — may lie in the strict time-keeping of pluripotent stem cells for each unique species.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mallory Ann Doyle, AGPCNP 9309 Holiday Dr, Louisville, KY 40272-2673 Ph: (989) 980-4797 | Mallory Ann Doyle, AGPCNP 105 Financial Pl, Elizabethtown, KY 42701-8437 Ph: (270) 765-5112 |
News Archive
Roche announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany.
CSL Behring announced today it has been granted national marketing authorization in Italy and Luxembourg to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. This latest authorization brings the number of countries to 28 (in Europe, Asia, North America, South America and Australia) in which Berinert is now licensed.
In a behind-the-scenes analysis of the U.S. Congress, Brown University political scientist Katrina Gamble found that black representatives put more time and resources than white representatives into developing policies and advocating for legislation of interest to African Americans.
Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
The mystery of what controls the range of developmental clocks in mammals — from 22 months for an elephant to 12 days for an opossum — may lie in the strict time-keeping of pluripotent stem cells for each unique species.
› Verified 1 days ago